The Pentagon wants ketamine wafers as a battlefield medicine option
The Pentagon wants ketamine wafers. And it seems to want them now. Earlier this year, the Defense Department…
Telehealth sees rising off-label use of GLP-1s for substance abuse
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Started a GLP-1 drug like Ozempic or Mounjaro? Here’s what you need to know about nutrition
Around half a million Australians use GLP-1 medications for diabetes – and when you add people who use…
Aaron Carter Estate Settles Walgreens Lawsuit Over Xanax Prescriptions
Aaron Carter‘s estate has reached a settlement in the wrongful death lawsuit filed on behalf of his toddler son…
We bought and tested what was sold as an experimental weight loss drug. The lab results were “pretty terrifying.”
A drug that’s not FDA approved and still in clinical trials is being advertised all over the internet.…
Blood thinners recalled nationwide over ‘life threatening’ foreign matter contamination
Nearly two dozen lots of a common blood thinner medication are being recalled after foreign matter was found…
Beauty Brands Target ‘Ozempic Face’ Market Amid Obesity Drug Surge, ETRetail
Swiss skincare firm Galderma, Brazilian cosmetics group Natura and beauty giant L’Oreal are testing treatments for consumers worried…
FDA recalls GLP-1 drug, other injectable medication over sterility concerns
article A woman holds a slimming syringe from Eli Lilly with the name Mounjaro and the active ingredient…
Tests of Unapproved Weight- Loss Drug Reveal Its Dangers
An obesity drug that hasn’t cleared federal safety checks is being hawked online and even at a…
Taking medicines for a chronic condition? 8 ways to avoid common treatment mistakes
Living with a chronic condition means medicines become part of daily life for years, and often for life.…
Beauty giants target ‘Ozempic face’ as boom in obesity drugs opens new market | Consumer
By Richa Naidu, Dominique Patton and Alexander Marrow LONDON/PARIS, Oct 21 (Reuters) – Swiss skincare firm Galderma, Brazilian…
TGA recalls common cold and flu ingredient over anaphylaxis risk
A herb found in dozens of complementary cold and flu supplements will no longer be classified as a…